These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7714116)

  • 1. Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity--clinical research center study.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstrom RW; Fujimoto WY
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1399-406. PubMed ID: 7714116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
    J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinsulin as a marker for the development of NIDDM in Japanese-American men.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstrom RW; Fujimoto WY
    Diabetes; 1995 Feb; 44(2):173-9. PubMed ID: 7859937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Røder ME; Porte D; Schwartz RS; Kahn SE
    J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstom RW; Fujimoto WY
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S63-6. PubMed ID: 8894485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
    Prigeon RL; Jacobson RK; Porte D; Kahn SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE; Halban PA
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
    Haffner SM; Gonzalez C; Mykkänen L; Stern M
    Diabetologia; 1997 Jul; 40(7):830-7. PubMed ID: 9243105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellitus.
    Røder ME; Vaag A; Hartling SG; Dinesen B; Lanng S; Beck-Nielsen H; Binder C
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2359-63. PubMed ID: 7629230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical significance of true insulin and proinsulin levels in subjects with different glucose tolerance].
    Yang J; Li M; Wu C
    Zhonghua Nei Ke Za Zhi; 2000 Dec; 39(12):811-3. PubMed ID: 11798541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of non-insulin-dependent diabetes mellitus and its risk factors in Japanese-Americans living in Hawaii and Los Angeles.
    Hara H; Egusa G; Yamakido M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S133-42. PubMed ID: 8894497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.
    Haffner SM; Bowsher RR; Mykkänen L; Hazuda HP; Mitchell BD; Valdez RA; Gingerich R; Monterossa A; Stern MP
    Diabetes; 1994 Dec; 43(12):1490-3. PubMed ID: 7958504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are insulin and proinsulin independent risk markers for premature coronary artery disease ?
    Katz RJ; Ratner RE; Cohen RM; Eisenhower E; Verme D
    Diabetes; 1996 Jun; 45(6):736-41. PubMed ID: 8635646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance.
    Shimizu M; Kawazu S; Tomono S; Ohno T; Utsugi T; Kato N; Ishi C; Ito Y; Murata K
    Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia.
    Birkeland KI; Torjesen PA; Eriksson J; Vaaler S; Groop L
    Diabetes Care; 1994 Nov; 17(11):1307-10. PubMed ID: 7821172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes.
    Smith SA; Porter LE; Biswas N; Freed MI
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6048-53. PubMed ID: 15579757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary heart disease and NIDDM in Japanese-Americans.
    Fujimoto WY; Bergstrom RW; Boyko EJ; Leonetti DL; Newell-Morris LL; Wahl PW
    Diabetes; 1996 Jul; 45 Suppl 3():S17-8. PubMed ID: 8674882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
    Røder ME; Schwartz RS; Prigeon RL; Kahn SE
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2275-80. PubMed ID: 10852463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.